Accendra Health, Inc. (ACH)
NYSE: ACH · Real-Time Price · USD
0.9509
-0.1491 (-13.55%)
At close: Aug 14, 2026, 4:00 PM EDT
0.9700
+0.0191 (2.01%)
After-hours: Aug 14, 2026, 7:59 PM EDT
Accendra Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,647 | 2,762 | 2,680 | 2,553 | 9,955 | 9,785 | |
Revenue Growth | -3.30% | 3.06% | 5.00% | -74.36% | 1.74% | 15.39% |
Cost of Revenue | 1,460 | 1,473 | 1,400 | 1,336 | 8,037 | 8,272 |
Gross Profit | 1,187 | 1,289 | 1,280 | 1,217 | 1,919 | 1,513 |
Selling, General & Admin | 1,038 | 1,069 | 1,084 | 1,004 | 1,557 | 1,079 |
Amortization of Goodwill & Intangibles | 116.92 | 73.83 | 39.85 | 57.8 | 78.97 | 39.77 |
Other Operating Expenses | - | - | - | - | -6.15 | -8.49 |
Operating Expenses | 1,155 | 1,143 | 1,124 | 1,062 | 1,630 | 1,111 |
Operating Income | 32.16 | 146.21 | 156.47 | 155.31 | 288.89 | 402.6 |
Interest Expense | -111.85 | -113.88 | -107.57 | -116.77 | -128.89 | -48.09 |
Currency Exchange Gain (Loss) | - | - | - | - | -0.9 | -2.3 |
Other Non Operating Income (Expenses) | -13.99 | -13.83 | -1.77 | -2.46 | -1.03 | -0.92 |
EBT Excluding Unusual Items | -93.69 | 18.49 | 47.13 | 36.08 | 158.06 | 351.3 |
Merger & Restructuring Charges | -4.5 | -120.45 | -68.81 | -24.34 | -54.9 | -34.11 |
Impairment of Goodwill | - | - | -307.11 | - | - | - |
Asset Writedown | - | - | - | - | -92.28 | - |
Other Unusual Items | -17.3 | - | -1.1 | 3.52 | - | -40.43 |
Pretax Income | -115.48 | -101.95 | -329.89 | 15.27 | 10.89 | 276.75 |
Income Tax Expense | -4.89 | 0.73 | 20.85 | 6.36 | -11.5 | 55.17 |
Earnings From Continuing Operations | -110.59 | -102.68 | -350.74 | 8.91 | 22.39 | 221.59 |
Earnings From Discontinued Operations | -191.55 | -997.96 | -11.95 | -50.21 | - | - |
Net Income | -302.14 | -1,101 | -362.69 | -41.3 | 22.39 | 221.59 |
Net Income to Common | -302.14 | -1,101 | -362.69 | -41.3 | 22.39 | 221.59 |
Net Income Growth | - | - | - | - | -89.90% | 641.82% |
Shares Outstanding (Basic) | 77 | 77 | 77 | 76 | 74 | 73 |
Shares Outstanding (Diluted) | 77 | 77 | 77 | 77 | 76 | 75 |
Shares Change | -0.47% | 0.20% | -0.81% | 1.51% | 0.97% | 18.85% |
EPS (Basic) | -3.94 | -14.31 | -4.73 | -0.54 | 0.30 | 3.05 |
EPS (Diluted) | -3.95 | -14.32 | -4.73 | -0.54 | 0.29 | 2.94 |
EPS Growth | - | - | - | - | -90.14% | 523.69% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -357.19 | -292.75 | -8.79 | 568.34 | 166.92 | 83.19 |
Free Cash Flow Per Share | -4.66 | -3.81 | -0.12 | 7.35 | 2.19 | 1.10 |
Dividend Per Share | - | - | - | - | - | 0.010 |
Dividend Growth | - | - | - | - | - | 0% |
Gross Margin | 44.84% | 46.68% | 47.77% | 47.68% | 19.27% | 15.46% |
Operating Margin | 1.21% | 5.29% | 5.84% | 6.08% | 2.90% | 4.11% |
Profit Margin | -11.41% | -39.85% | -13.53% | -1.62% | 0.22% | 2.27% |
Free Cash Flow Margin | -13.49% | -10.60% | -0.33% | 22.26% | 1.68% | 0.85% |
EBITDA | 288.23 | 360.74 | 337.75 | 365.68 | 503.55 | 482.92 |
EBITDA Margin | 10.89% | 13.06% | 12.60% | 14.33% | 5.06% | 4.93% |
D&A For EBITDA | 256.08 | 214.52 | 181.28 | 210.37 | 214.67 | 80.32 |
EBIT | 32.16 | 146.21 | 156.47 | 155.31 | 288.89 | 402.6 |
EBIT Margin | 1.21% | 5.29% | 5.84% | 6.08% | 2.90% | 4.11% |
Effective Tax Rate | - | - | - | 41.66% | - | 19.93% |